Metabolic profiles and fingerprints for the investigation of the influence of nitisinone on the metabolism of the yeast Saccharomyces cerevisiae.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 01 2023
26 01 2023
Historique:
received:
20
10
2022
accepted:
17
01
2023
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
31
1
2023
Statut:
epublish
Résumé
Nitisinone (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione, NTBC) is considered a potentially effective drug for the treatment of various metabolic diseases associated with disorders of L-tyrosine metabolism however, side-effects impede its widespread use. This work aimed to broaden the knowledge of the influence of NTBC and its metabolites 2-amino-4-(trifluoromethyl)benzoic acid (ATFA), 2-nitro-4-(trifluoromethyl)benzoic acid (NTFA), and cyclohexane-1,3-dione (CHD) on the catabolism of L-tyrosine and other endogenous compounds in Saccharomyces cerevisiae. Based on a targeted analysis performed by LC-ESI-MS/MS, based on multiple reaction monitoring, it was found that the dissipation kinetics of the parent compound and its metabolites are compatible with a first-order reaction mechanism. Moreover, it has been proven that formed NTBC metabolites, such as CHD, cause a decrease in L-tyrosine, L-tryptophan, and L-phenylalanine concentrations by about 34%, 59% and 51%, respectively, compared to the untreated model organism. The overall changes in the metabolism of yeast exposed to NTBC or its derivatives were evaluated by non-targeted analysis via LC-ESI-MS/MS in the ion trap scanning mode. Based on principal components analysis, a statistically significant similarity between metabolic responses of yeast treated with ATFA or NTFA was observed. These findings facilitate further studies investigating the influence of NTBC on the human body and the mechanism of its action.
Identifiants
pubmed: 36702867
doi: 10.1038/s41598-023-28335-3
pii: 10.1038/s41598-023-28335-3
pmc: PMC9879944
doi:
Substances chimiques
nitisinone
K5BN214699
4-Hydroxyphenylpyruvate Dioxygenase
EC 1.13.11.27
Cyclohexanones
0
Nitrobenzoates
0
Tyrosine
42HK56048U
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1473Informations de copyright
© 2023. The Author(s).
Références
Biochim Biophys Acta. 2008 Apr;1783(4):629-40
pubmed: 18039473
Neurochem Int. 2012 Dec;61(8):1370-4
pubmed: 23046746
J Pharm Biomed Anal. 2019 Jul 15;171:15-21
pubmed: 30959315
Chemosphere. 2022 Jan;286(Pt 1):131592
pubmed: 34311397
PLoS One. 2011 Feb 02;6(2):e16015
pubmed: 21311596
Methods Enzymol. 1991;194:3-21
pubmed: 2005794
Rapid Commun Mass Spectrom. 2010 Mar;24(6):791-800
pubmed: 20187082
Biotechnol J. 2008 Mar;3(3):325-38
pubmed: 18228539
Adv Biomed Res. 2018 Jan 22;7:7
pubmed: 29456978
Lancet Diabetes Endocrinol. 2021 Jul;9(7):427-435
pubmed: 34023005
Biotechnol Genet Eng Rev. 2006;22:213-52
pubmed: 18476333
Metabolites. 2022 May 25;12(6):
pubmed: 35736410
Bone. 2021 May;146:115881
pubmed: 33578033
Mol Genet Metab Rep. 2022 Feb 01;30:100846
pubmed: 35242577
J Neurosci. 1999 May 1;19(9):3519-26
pubmed: 10212311
JIMD Rep. 2018;41:1-10
pubmed: 29147990
Microb Biotechnol. 2021 Nov;14(6):2420-2434
pubmed: 33438818
Prog Nucleic Acid Res Mol Biol. 2002;72:41-94
pubmed: 12206458
J Inherit Metab Dis. 2020 Sep;43(5):1014-1023
pubmed: 32083330
Neuropharmacology. 2004 Sep;47(3):438-49
pubmed: 15275833
Chemosphere. 2020 Apr;245:125616
pubmed: 31864055
Genes Dis. 2021 Feb 22;9(4):1129-1142
pubmed: 35685462
Microb Cell Fact. 2007 Oct 10;6:32
pubmed: 17927824
Neurosci Biobehav Rev. 2022 Jan;132:838-856
pubmed: 34774900
Mol Genet Metab. 2018 Sep;125(1-2):135-143
pubmed: 30049652